William J Febbo is CEO of OptimizeRx Corp. Currently has a direct ownership of 581,253 shares of OPRX, which is worth approximately $2.57 Million. The most recent transaction as insider was on Apr 18, 2024, when has been sold 782 shares (Common Stock) at a price of $9.35 per share, resulting in proceeds of $7,311. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 581K
0% 3M change
23.3% 12M change
Total Value Held $2.57 Million

WILLIAM J FEBBO Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 18 2024
SELL
Payment of exercise price or tax liability
$7,311 $9.35 p/Share
782 Reduced 0.13%
581,253 Common Stock
Apr 18 2024
BUY
Exercise of conversion of derivative security
-
28,895 Added 4.73%
582,035 Common Stock
Apr 15 2024
BUY
Grant, award, or other acquisition
-
60,000 Added 10.03%
538,144 Common Stock
Feb 15 2024
BUY
Grant, award, or other acquisition
-
15,000 Added 2.64%
553,144 Common Stock
Jan 09 2024
SELL
Payment of exercise price or tax liability
$38,213 $13.25 p/Share
2,884 Reduced 0.6%
478,144 Common Stock
Jan 09 2024
BUY
Exercise of conversion of derivative security
-
9,628 Added 1.96%
481,028 Common Stock
Jan 07 2023
BUY
Exercise of conversion of derivative security
-
9,628 Added 2.0%
471,400 Common Stock
Aug 22 2022
BUY
Open market or private purchase
$163,603 $15.29 p/Share
10,700 Added 2.26%
461,772 Common Stock
Aug 19 2022
BUY
Open market or private purchase
$87,372 $16.18 p/Share
5,400 Added 1.18%
451,072 Common Stock
Feb 18 2022
SELL
Open market or private sale
$735,804 $44.15 p/Share
16,666 Reduced 3.6%
445,672 Common Stock
Jan 18 2022
SELL
Open market or private sale
$794,468 $47.67 p/Share
16,666 Reduced 3.48%
462,338 Common Stock
Jan 07 2022
BUY
Payment of exercise price or tax liability
-
9,627 Added 1.97%
479,004 Common Stock
Dec 15 2021
SELL
Open market or private sale
$909,130 $54.55 p/Share
16,666 Reduced 3.43%
469,377 Common Stock (pursuant...
Nov 15 2021
SELL
Open market or private sale
$1,369,612 $82.18 p/Share
16,666 Reduced 3.32%
486,043 Common Stock (pursuant...
Oct 15 2021
SELL
Open market or private sale
$1,403,277 $84.2 p/Share
16,666 Reduced 3.21%
502,709 Common Stock (pursuant...
Sep 15 2021
SELL
Open market or private sale
$1,095,623 $65.74 p/Share
16,666 Reduced 3.11%
519,375 Common Stock (pursuant...
Sep 13 2021
SELL
Bona fide gift
-
8,600 Reduced 1.58%
536,041 Common Stock
Aug 16 2021
SELL
Open market or private sale
$1,007,626 $60.46 p/Share
16,666 Reduced 2.97%
544,641 Common Stock (pursuant...
Mar 25 2021
SELL
Open market or private sale
$3,688,000 $46.1 p/Share
80,000 Reduced 29.27%
193,278 Common Stock
Mar 25 2021
SELL
Payment of exercise price or tax liability
$1,267,122 $47.44 p/Share
26,710 Reduced 4.54%
561,307 Common Stock
Mar 25 2021
BUY
Exercise of conversion of derivative security
$1,267,112 $3.21 p/Share
394,739 Added 40.17%
588,017 Common Stock
Mar 24 2021
SELL
Open market or private sale
$1,010,000 $50.5 p/Share
20,000 Reduced 6.82%
273,278 Common Stock
Dec 31 2020
BUY
Exercise of conversion of derivative security
-
21,186 Added 6.74%
293,278 Common Stock
Sep 30 2020
BUY
Exercise of conversion of derivative security
-
21,186 Added 7.22%
272,092 Common Stock
Mar 31 2020
BUY
Exercise of conversion of derivative security
-
21,187 Added 7.79%
250,906 Common Stock

Also insider at

MODD
Modular Medical, Inc. Healthcare
AUGX
Augmedix, Inc. Healthcare
LFMD
LifeMD, Inc. Healthcare
WJF

William J Febbo

CEO
San Diego, CA

Track Institutional and Insider Activities on OPRX

Follow OptimizeRx Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OPRX shares.

Notify only if

Insider Trading

Get notified when an Optimize Rx Corp insider buys or sells OPRX shares.

Notify only if

News

Receive news related to OptimizeRx Corp

Track Activities on OPRX